Why Viking Therapeutics Stock Rocked the Market Today
The Motley FoolThe biotech continued to get attention from both pundits and investors, thanks largely to its investigational obesity drug.
The biotech continued to get attention from both pundits and investors, thanks largely to its investigational obesity drug.